(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks. The FTSE 100 index closed up 0.59% at 8,684.44 points, while the FTSE 250 ...

HCDPQHarbor Custom Development, Inc. 8% CONV PFD SR A Harbor Custom Development, Inc. 8% CONV PFD SR A ...

FBIOPFortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 Fortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 NHPAPNational Healthcare Properties, Inc. 7.375% CUM RED REP PFD ...

But today, Kendall has been reborn — as the glittering, glassy heart of America’s biotech industry. For many companies, Kendall Square’s status as a global center of biotechnology firms and ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

LONDON, April 14 (Reuters) - Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

In this article, we will be taking a look at the 7 most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...